Trending
November 4, 2024

Alexandria Venture Investments Join $10M Seed Financing For CrossBridge Bio

November 4, 2024

Neurogene Announces $200 Million Private Placement

November 4, 2024

Cornucopian Capital Joins $20M Round for Archon Biosciences

November 4, 2024

CarePoint Initiates Financial Restructuring

October 31, 2024

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

October 31, 2024

MiNK Therapeutics Appoints Dr. Robert Kadlec to Board of Directors

October 31, 2024

Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

October 31, 2024

Merck Announces Third-Quarter 2024 Financial Results

October 30, 2024

Orthobond Appoints George Landau as EVP, Business Development and Commercialization

October 30, 2024

Alexandria Venture Investments Join $115 Million Series A For Axonis Therapeutics

October 30, 2024

Alexandria Venture Investments Joins $45M Financing For Leal Therapeutics

October 30, 2024

Northpond Ventures-Backed Transition Bio Raises $13.3M

October 29, 2024

Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

October 28, 2024

Resalis Therapeutics Gains Strategic Equity Investment from Sanofi

October 25, 2024

BD Named Among the 100 Best Corporate Citizens of 2024

October 24, 2024

Insmed Ranks No. 1 on Science’s 2024 Top Biopharma Employers List